Cargando…

The Potential Application and Promising Role of Targeted Therapy in Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a rare yet serious progressive disorder that is currently incurable. This female-predominant disease unfolds as a pan-vasculopathy that affects all layers of the vessel wall. Five classes of pharmacological agents currently exist to target the three major cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsieh, Meng-Chien Willie, Wang, Wei-Ting, Yeh, Jwu-Lai, Lin, Chuang-Yu, Kuo, Yur-Ren, Lee, Su-Shin, Hou, Ming-Feng, Wu, Yi-Chia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220101/ https://www.ncbi.nlm.nih.gov/pubmed/35740436 http://dx.doi.org/10.3390/biomedicines10061415

Ejemplares similares

Glucagon-Like Peptide-1 Receptor Agonist Attenuates Autophagy to Ameliorate Pulmonary Arterial Hypertension through Drp1/NOX- and Atg-5/Atg-7/Beclin-1/LC3β Pathways
por: Wu, Yi-Chia, et al.
Publicado: (2019)

Stem Cell-Based Therapeutic Strategies in Diabetic Wound Healing
por: Hsieh, Meng-Chien Willie, et al.
Publicado: (2022)

Telemedicine algorithm for chronic wound care during COVID‐19
por: Hsieh, Meng‐Chien Willie, et al.
Publicado: (2020)

Application of nanofat grafting to rescue a severe ischaemic hand with thromboangiitis obliterans: A case report about promising salvage procedure
por: Ng, Kwan Lok Benjamin, et al.
Publicado: (2021)

Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways
por: Lee, Mei-Yueh, et al.
Publicado: (2016)

Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2022)

CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension
por: Tomaszewski, Michał, et al.
Publicado: (2022)

The Xanthine Derivative KMUP-1 Attenuates Serotonin-Induced Vasoconstriction and K(+)-Channel Inhibitory Activity via the PKC Pathway in Pulmonary Arteries
por: Dai, Zen-Kong, et al.
Publicado: (2015)

Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy
por: Dai, Lingling, et al.
Publicado: (2022)

Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension
por: Zeng, Cheng, et al.
Publicado: (2023)

Recipient Adipose-Derived Stem Cells Enhance Recipient Cell Engraftment and Prolong Allotransplant Survival in a Miniature Swine Hind-Limb Model
por: Kuo, Yur-Ren, et al.
Publicado: (2017)

MMP-10 from M1 macrophages promotes pulmonary vascular remodeling and pulmonary arterial hypertension
por: Chi, Pei-Ling, et al.
Publicado: (2022)

Differential Response of Non-cancerous and Malignant Breast Cancer Cells to Conditioned Medium of Adipose tissue-derived Stromal Cells (ASCs)
por: Wu, Yi-Chia, et al.
Publicado: (2019)

The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction
por: Chen, I-Chen, et al.
Publicado: (2020)

Comparing Extracorporeal Shockwave and Hyperbaric Oxygen Therapy in Enhancing Wound Healing in a Streptozotocin-Induced Diabetic Rodent Model
por: Kuo, Yur-Ren
Publicado: (2022)

The application and value of continuous nursing in patients after coronary artery bypass grafting
por: Zhou, Sheng-Huo, et al.
Publicado: (2020)

Does pulmonary artery pulsatility index predict mortality in pulmonary arterial hypertension?
por: Lim, Yinghao, et al.
Publicado: (2021)

Foraging for the Optimal Dressing Scaffold to Carry Adipose-Derived Stromal/Progenitor Cells for Cell Therapy
por: Wu, Chia-Chieh, et al.
Publicado: (2022)

Immunomodulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells in a Swine Hemi-Facial Allotransplantation Model
por: Kuo, Yur-Ren, et al.
Publicado: (2012)

Angiotensin-Converting Enzyme 2 Activator Ameliorates Severe Pulmonary Hypertension in a Rat Model of Left Pneumonectomy Combined With VEGF Inhibition
por: Chen, I-Chen, et al.
Publicado: (2021)

The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension
por: Ormiston, Mark L., et al.
Publicado: (2015)

Role of Extracellular Matrix in Pathophysiology of Patent Ductus Arteriosus: Emphasis on Vascular Remodeling
por: Lin, Ting-Yi, et al.
Publicado: (2020)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Pulmonary Arterial Hypertension
por: Michelakis, Evangelos D., et al.
Publicado: (2007)

The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension
por: Zeng, Wei-Jie, et al.
Publicado: (2012)

Microarray profiling of long noncoding RNAs associated with idiopathic pulmonary arterial hypertension
por: Han, Bing, et al.
Publicado: (2019)

Role of chymase in cigarette smoke-induced pulmonary artery remodeling and pulmonary hypertension in hamsters
por: Wang, Tao, et al.
Publicado: (2010)

Risk factors of neurological deficit and pulmonary cement embolism after percutaneous vertebroplasty
por: Hsieh, Ming-Kai, et al.
Publicado: (2019)

Social determinants of health in pulmonary arterial hypertension patients in the United States: Clinician perspective and health policy implications
por: Nadipelli, Vijay R., et al.
Publicado: (2022)

Pulmonary hypertension and pulmonary artery dissection
por: Corrêa, Ricardo de Amorim, et al.
Publicado: (2013)

Diffuse Pulmonary Arteriovenous Fistulas With Pulmonary Arterial Hypertension: Case Report and Review
por: Jiang, Rong, et al.
Publicado: (2016)

Is pulmonary arterial hypertension associated with schistosomiasis distinct from pulmonary arterial hypertension associated with portal hypertension?
por: Graham, Brian B., et al.
Publicado: (2023)

Pulmonary hypertension complicating unilateral absence of pulmonary artery and coronary‐pulmonary artery fistula: Report of a case and review of the literature
por: Lin, Chen‐Chieh, et al.
Publicado: (2022)

Serum Caveolin-1 as a Novel Biomarker in Idiopathic Pulmonary Artery Hypertension
por: Wang, Kuo-Yang, et al.
Publicado: (2015)

Benefits of Curcumin in the Vasculature: A Therapeutic Candidate for Vascular Remodeling in Arterial Hypertension and Pulmonary Arterial Hypertension?
por: Li, Ke-Xue, et al.
Publicado: (2022)

Role of macrophages in pulmonary arterial hypertension
por: Zhang, Meng-Qi, et al.
Publicado: (2023)

ACE2, a promising therapeutic target for pulmonary hypertension
por: Shenoy, Vinayak, et al.
Publicado: (2011)

Vasculoprotective effects of Centella asiatica, Justicia gendarussa and Imperata cylindrica decoction via the NOXs-ROS-NF-κB pathway in spontaneously hypertensive rats
por: Sulistyowati, Erna, et al.
Publicado: (2019)

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
por: Yeo, Jina, et al.
Publicado: (2022)

Microarray profiling of long non-coding RNAs associated with idiopathic pulmonary arterial hypertension
por: Han, Bing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0eujsrf2sekbeuo80ivv7e4its